Ask a doctor about a prescription for MEDSAMIC 100 mg/mL Injectable Solution
Package Leaflet: Information for the User
Medsamic 100 mg/ml Solution for Injection EFG
tranexamic acid
Read this package leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the Package Leaflet
Contents of the pack and further information
Medsamic solution for injection contains tranexamic acid, which belongs to a group of medicines called antihemorrhagics, antifibrinolytics, amino acids.
This medicine is used in adults and children over 1 year of age to prevent and treat bleeding due to a process that inhibits blood coagulation called fibrinolysis.
The specific indications include the following:
Bleeding after treatment with another medicine to dissolve blood clots.
Do not use Medsamic:
Due to the risk of cerebral edema and seizures, intrathecal and intraventricular injection and intracerebral application are not recommended.
If you think any of these situations apply to you, or if you have any doubts, talk to your doctor before using this medicine.
Warnings and precautions
Talk to your doctor before you start using Medsamic.
Tell your doctor if you are in any of these situations to help them decide if Medsamic is suitable for you:
Other medicines and Medsamic
Tell your doctor, nurse, or pharmacist if you are taking, have recently taken, or might take any other medicines.
Specifically, you should tell them if you use:
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Tranexamic acid is excreted in breast milk, therefore, the use of this medicine is not recommended during breastfeeding.
Driving and using machines
No studies have been performed on the ability to drive and use machines.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. Ask your doctor or pharmacist if you are not sure.
Use in adults
The Medsamic solution for injection will be administered to you by slow injection into a vein.
Your doctor will decide the correct dose for you and for how long you should receive it.
Use in children
If this medicine is given to a child over 1 year of age, the dose should be based on the child's weight. The doctor will decide the correct dose for the child and for how long they should receive it.
Use in elderly patients
No dose reduction is necessary unless there are signs of renal insufficiency.
Use in patients with kidney problems
If you have kidney problems, the dose of tranexamic acid will be reduced according to the results of a blood test (serum creatinine level).
Use in patients with liver insufficiency
No dose reduction is necessary.
Method of administration
This medicine should only be administered slowly into a vein.
This medicine should not be injected into a muscle.
If you use more Medsamic than you should
If you have received a higher dose of Medsamic than recommended, you may experience a temporary drop in blood pressure. Talk to your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, talk to your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects reported with tranexamic acid are as follows:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Frequency not known (cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible that they are not listed in this package leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the label after "EXP". The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Medsamic
Each 1 ml of solution contains 100 mg of tranexamic acid.
Each 5 ml ampoule contains 500 mg of tranexamic acid.
Each 10 ml ampoule contains 1000 mg of tranexamic acid.
Appearance and packaging
5 ml glass ampoules type I. Boxes of 5 ampoules x 5 ml.
10 ml glass ampoules type I. Boxes of 5 ampoules x 10 ml.
5 ml glass ampoules type I. Boxes of 10 ampoules x 5 ml.
10 ml glass ampoules type I. Boxes of 10 ampoules x 10 ml.
Not all pack sizes may be marketed.
Marketing authorization holder
Medochemie Limited
1-10 Constantinoupoleos Street
3011 Limassol
Cyprus
Manufacturer
Medochemie Ltd. - Ampoule Injectable Facility
48 Iapetou Street, Agios Athanassios Industrial Area
4101 Limassol
Cyprus
You can ask for more information about this medicine from the local representative of the marketing authorization holder:
Local representative:
Medochemie Iberia S.A., Sucursal en España
Avenida de las Águilas, nº 2 B; planta 5 oficina 6,
28044 Madrid
SPAIN
Date of last revision of this package leaflet: 01/2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of MEDSAMIC 100 mg/mL Injectable Solution in October, 2025 is around 8.24 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MEDSAMIC 100 mg/mL Injectable Solution – subject to medical assessment and local rules.